chrisvoncsefalvay/vaers-outcomes huggingface dataset:
armpit swollen and sore; armpit hot to the touch; neck is swollen; It is difficult to do anything; armpit swollen and sore; tenderness at the injection site; pain in her L arm (injection site); This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (armpit swollen and sore), FEELING HOT (armpit hot to the touch), SWELLING (neck is swollen), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (It is difficult to do anything) and AXILLARY PAIN (armpit swollen and sore) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A-1) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced SWELLING (armpit swollen and sore), FEELING HOT (armpit hot to the touch), SWELLING (neck is swollen), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (It is difficult to do anything), AXILLARY PAIN (armpit swollen and sore), VACCINATION SITE PAIN (tenderness at the injection site) and VACCINATION SITE PAIN (pain in her L arm (injection site)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SWELLING (armpit swollen and sore), FEELING HOT (armpit hot to the touch), SWELLING (neck is swollen), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (It is difficult to do anything), AXILLARY PAIN (armpit swollen and sore), VACCINATION SITE PAIN (tenderness at the injection site) and VACCINATION SITE PAIN (pain in her L arm (injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment information was provided.
Calcium level increase and Vitamin D level increase that led to confusion, slurred speech and extreme fatigue.
Fever of 100.9 °F for over 24 hours, chills, muscle pain, headaches, dizziness, loss of appetite, swollen arm and redness around injection site, tiredness, sweatiness for 48 hours.
This spontaneous report received from a consumer, concerned a female of unspecified age. Medical history, concurrent conditions, concomitant medications, weight and height not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch/lot number: not reported) dose: not reported, on Apr 7, 2021, for immunization. Unable to perform follow-up to request batch/lot numbers. On an unspecified date, patient experienced lightheadedness/feeling worse and tired. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome: not reported. This case (same reporter) linked to 20220407428.
Rash to chest and neck area started around 6pm  on 12/19/20 and it is current today 1/14/21 but fading
Information has been received from a family member concerning an 84 year old female with asthma chronic who in June 2007, was a dose of vaccinated with ZOSTAVAX (Merck) in a pharmacy, without getting advice from her primary physician. Concomitant therapy included corticosteroids (unspecified). She had been on corticosteroids (unspecified) for 50 years to treat her asthma. In June 2007, the patient got shingles. The blisters had gone away but the pain never ceased. The patient was currently on LYRICA for pain. The patient did not receive medical attention. At the time of the reporting, the patient had not recovered. Additional information is not expected.
The patient had hives every day since then; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via media on 28-Dec-2020.  This case involves a 59-year-old female patient who had hives every day (Urticaria), while the patient received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On 01-Dec-2020, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On 01-Dec-2020 in afternoon, the patient stated that she had one INFLUENZA VACCINE, and had hives every day since then (Urticaria).   The patient would like to know what the ingredients were of this vaccine so that she could trace it back to see what ingredient(s) that might had caused this reaction.  It was not reported if the patient received any corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
I had chills, nausea, body pain, headaches, and over-sensitivity to lights and sounds. The symptoms lasted more than 36 hours but less than 48 hours. I haven't eaten anything yet, but I am feeling better today.
Shortness of breath; Can't eat; Lightheaded; Nauseated; Throwing up; This is a spontaneous report from a contactable consumer, the patient. This 57-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161; Expiration Date: 31Jul2021), via an unspecified route of administration in the right arm on 17Apr2021 14:30 (at the age of 57-year-old) as a single dose for COVID-19 immunization. The patient was not enrolled in any clinical study or program. Medical history included ongoing chronic obstructive pulmonary disease (COPD), ongoing Crohn's disease, ongoing diabetes mellitus, ongoing neuropathy peripheral, and ongoing liver disorder. The patient had allergic to a lot of antibiotics; she is allergies to metronidazole, Compazine, she is very highly allergic to Compazine, Penicillin, Augmentin, Bactrim, Iodine, Sulfa, IV contrast (iodine), Prozac and Avelox; the allergies to these medications occurred years ago with the same type of reactions with all these medications: Her throat closes up, she turns black and blue (bruising), or she vomits. Concomitantly, the patient takes medications but does not feel her medications are relevant. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730, Expiry Date: 31Jul2021); via an unspecified route of administration in the left arm on 27Mar2021 at 14:30 (at the age of 57-year-old) as a single dose for COVID-19 immunization. The patient reported she had her second Covid 19 vaccine on 17Apr2021, it seems like the next day on 18Apr2021, she didn't feel that good where she has been nauseated, lightheaded, throwing up, can't eat and has shortness of breath. Every day it seems worse. She doesn't know if she's sick with something else or if it's the vaccine. She called and spoke with her doctor and her doctor didn't know if her symptoms were related to the Covid 19 vaccine or maybe she had bronchitis or COPD (since she does have a history of COPD). No investigation assessment reported. The patient also called her liver doctor who told her to call and report her symptoms to Pfizer. Her symptoms are still persisting. The clinical outcomes of the events, nauseated, lightheaded, throwing up, can't eat and has shortness of breath were not resolved.
After receiving the second dose of Pfizer, I began to feel an ache in my chest area around location of heart.  It did not feel like what I have read a heart attack feels like, just an intermittent ache to the heart area.  This sensation lasted approximately two days.
expired dose administered to 3 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered to 3 patients) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 20-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered to 3 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose administered to 3 patients) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was reported. The vial was initially stored in the refrigerator on 09-May-2022. HCP stated that they had Moderna at the facility which showed as expired on 17-May-2022 upon entering into the expiration look up tool on Moderna's website. It was reported that the vial did not undergo any temperature excursions. None of the patients have reported any adverse reactions to the expired dose. No treatment drug was reported.
Child received an MMR from the PHN at the school on 10/24/17. Three weeks later he was admitted to Hospital in a somnolent state. He was diagnosed with an acquired brain injury, encephalitis of unknown origin. All tests were negative for pathogens or other traumatic causes. He had had a cold prior to admission so they treated it as if it were a post-infectious/autoimmune cause and he was treated with IVIG and steroids as well as antibiotics and antiviral medication. He was in the PICU for 2 weeks with right sided weakness, impaired cognition and extreme somnolence. He then went to another Hospital for rehab. He continues to improve and has been discharged home approximately 5 weeks after admission.
I received vaccine and within 4 hours I was unable to continue my day mild fever; couldn't catch my breath;
he experience soreness at the injection site as well as a temperature of 101; he experience soreness at the injection site as well as a temperature of 101; This spontaneous report as received from a consumer referring to her husband a male patient of unknown age. The patient's concurrent conditions, past medical history and concomitant medications were not reported.  On 03-DEC-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) 1 shot (dose, frequency, route and anatomical location were not provided) for prophylaxis. On 04-DEC-2019, the patient experienced soreness at the injection site (injection site pain) as well as temperature of 101 (body temperature abnormal), as treatment he received acetaminophen (TYLENOL) and he did not sought medical attention. The outcome of injection site pain and body temperature abnormal was reported as not recovered.  The causality assessment between the events and pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not reported.
Rash over body started on arms, spread to trunk and legs. Benadryl 25mg QID.
inflamed lymph nodes/ no swollen lymph node prior to vaccination; inflamed lymph nodes/ no swollen lymph node prior to vaccination; This is a spontaneous report received from a contactable reporter(s) (nurse). The reporter is the patient.  A 55 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in left deltoid, administration date 22Jan2021 (Lot number: EL3247) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Parkinson's disease", start date: 2017 (unspecified if ongoing); "Breast cancer", start date: 2018 (unspecified if ongoing); "Breast cancer surgery" (unspecified if ongoing). Concomitant medication(s) included: RYTARY taken for parkinson's disease; SELEGILINE; CLARITIN [LORATADINE]; VITAMIN D NOS; VITAMIN C [ASCORBIC ACID]; ZINC; PROBIOTICS; TURMERIC [CURCUMA LONGA]. The following information was reported: LYMPHADENITIS (non-serious), LYMPHADENOPATHY (non-serious) all with onset 23Jan2021, outcome "not recovered" and all described as "inflamed lymph nodes/ no swollen lymph node prior to vaccination". The event "inflamed lymph nodes/ no swollen lymph node prior to vaccination" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenitis, lymphadenopathy.
I experienced moderate fever and mild headache 12-14 hrs post dose.; I experienced moderate fever and mild headache 12-14 hrs post dose.; I received the 3rd booster shot yesterday; I received the 3rd booster shot yesterday; This is a spontaneous report from a contactable consumer (patient) reported herself. A 45-years-old female patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: unknown), via an unknown route of administration on 22Aug2021 as dose 3, single for COVID-19 immunization at hospital. The patient's medical history included autoimmune condition. Concomitant medication was not reported. The patient received BNT162B2 on an unknown date as historical vaccine as dose 1 and dose 2, single for covid-19 immunization. On 22Aug2021, the patient experienced moderate fever and mild headache 12-14 hrs post dose. I received the 3rd booster shot yesterday. Event took place after use of product. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
After receiving flu shot on 12/10/2019 patient started filling uncomfortably hot. First symptoms started 10 to 15 min after the imz administration.  Patient started feeling unwell, felt that she is loosing her focus and scratchy trough. She had extreme pain in her left arm that lasted approx 7 days, she had flu like symptoms for approx 7 days (chills, dizziness, nausea and vomiting   , dehydration.) Overall she felt unwell for 7 days and haven't left her house.  She had flu shot before with no known reaction. She have't called to report reactions before ( approx 40 days since administration) because she was sick and busy.
Patient stated started feeling ? lightheaded, dizzy and short of breath? Patient provided with water and symptoms improved  Patient refused medical transport and signed form
Temp of over 100 up to 103 Bad headache Late in second day symptoms were like MS exacerbation, weak, unable to walk
Information has been received from a registered nurse concerning a 56 year old white female who on 5/29/03 was vaccinated IM in the right arm (deltoid) with a second booster dose of pneumococcal vaccine 23 polyvalent 0.5ml/dose (lot number 643503/0541M). On 5/30/03 the patient started to get a sore arm. Later that night, the patient could not sleep, felt extremely cold and had chattering teeth. On 5/31/03 the patient felt lethargic and ill. That evening, she slept for 10 hours. On 6/1/03 the patient felt better but her arm was still sore and inflamed. Unspecified medical attention was sought. There was no product quality complaint involved. The nurse also reported on another patient who experienced a similar reaction with pneumococcal vaccine 23 polyvalent (lot # 643503/0541M). Additional information has been requested.
approx 1.5hr p/vax c/o of tightness in thraot & swelling of the lower lips;seen ER;c/o inc nause;no vomiting;
Patient experienced bruising in the 2 weeks following vaccine with critical platelets of 8.  No history of thrombocytopenia prior to receiving the vaccine
10 minutes after vaccine administration pt stated he started to feel dizzy like he might pass out. After pt was moved from outside into an air conditioned mobile unit, provided water and a snack pt began to feel much better. Pt was monitored for 15 additional minutes at which point he stated ? he feels 100% ? pt was released.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Oct2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 05Nov2021 as dose 2, single (Batch/Lot number: unknown) at the age of 64 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "Known allergies: Ivp dye" (unspecified if ongoing); "Known allergies: Pcn" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid).   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Considering the nature of the reported events and product profile, a causal role of the suspect BNT162B2 cannot be denied for the reported events.
Moderna COVID 19 First day fine, second day burning sensation in arm, followed by a hardness, then redness, then bruising, then itching and redness spreading to the upper arm. Still have a burning sensation with the itching and redness.  Today went to pharmacy and they suggested I report this.  I purchased calcimine lotion and if that does not work, they recommended I take Benadryl.
Paralyzed; This case was reported by a consumer via interactive digital media and described the occurrence of paralysis in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis was recovering/resolving.   The reporter considered the paralysis to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were reported as follows: The age at vaccination was not reported. Consumer reported that, friend of mine got paralyzed from flu shot six months recovering still had problems.
Breakthrough COVID-19 infection. Patient tested positive on Aug 31 2021. Patient was fully vaccinated on JULY 2, 2021.
Information has been received from a physician concerning a female (age not reported), who was vaccinated in approximately MAY 2008, with a dose of GARDASIL.  The physician reported that within 15 minutes after she was vaccinated she fainted.  Subsequently the patient recovered.  Additional information has been requested.
Varicella like type of rash to trunchal area 24 hrs after receiving 2nd dose of varicella vaccine. Given on 9/11/12. Treatment not given.
p/vax pt exp fever early eve. woke up on 7/3/99 w/swollen face, ears, lips & hives & itching. treated w/benadryl
This case was reported by a consumer via sales rep and described the occurrence of blistery rash in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 10 days after receiving SHINGRIX, the patient experienced blistery rash and blister. On an unknown date, the outcome of the blistery rash and blister were unknown. It was unknown if the reporter considered the blistery rash and blister to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experiencing a blistering rash that began about 10 days after SHINGRIX vaccination. It has been 2 weeks at the reporting time since the shot and the patient was still getting more blisters. The blisters were on legs with most below knees. The patient was asking whether this was a normal reaction, or she should visit her physician. She also asked if she should get the second dose.
back pain; A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: BACK PAIN (non-serious), outcome "unknown", described as "back pain". Therapeutic measures were taken as a result of back pain. Additional information: The patient took tramadol due back pain. The patient wanted to know if he is allowed to continue the pain reliever.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My left arm was sore at injection site.  The 5 finger (pinky) on left was blue/purple in the first and second digit moving to 3rd digit.  Called family Dr., recommended to go to Urgent Care/hospital.  Urgent Care sent me to the hospital.  Ref to Vascular Surgeon .  Each day for next 7 day condition worsens returned to ER, hand drawn inward, finger tip numb and still discolored with severe pain.  I was administered morphine for pain, CT scan, EKG, blood work.  Vascular Dr.  Prescribed meds.  I am 21 days following 2d shot, still in pain with swelling and limited use of hand.
Rash all over body and bruising that looks like clotting. I have pictures, went to see my doctor and he was dismissive and mean. I just want to know what?s wrong and how to make it go away.
Patient reported feeling numbness to her hands and red patches appeared on her face and neck. Patient was assessed and symptoms were monitored. After an additional 15 minutes of observation, the numbness to the hands and the red patches on face and neck disappeared. Patient left vaccination clinic in stable condition.
MAJOR BLOOD CLOTS; This spontaneous report received from a patient via a company representative via a social media  concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s ((suspension for injection, route of admin, and batch number were not reported) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced major blood clots and never had them before. The patient was on blood thinner and reported a clot in leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of major blood clots was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211152736- Covid-19 vaccine ad26.cov2.s-major blood clots. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
On 5/19/02 AM, developed tactile temperature with red, spotty "pox" marks which progressed throughout the day. Child now covered head to toe in all areas with "pox" marks per mom. Tactile temperature on 5/19/02 AM was reported to me by mom on 5/20/02 AM. Addendum: Change in rash (hive-like). Hospitalized X 1 day for erythema multiforme (minor). Not yet recovered.
Information has been received from a physician via field employee referring to a 30 year old female. There was no concurrent condition or medical history reported. On unknown dates the patient was vaccinated with full three dose series of unidentified Merck HPV vaccine (name and lot number not provided). After the three dose series completed, on 05-OCT-2015, the patient performed a routine examination which included pap smear and other standard tests. The patient tested positive for HPV type 16 it was not known if the patient contracted HPV type 16 prior to administration of GARDASIL or after. The outcome of the events was reported as not recovered. Additional information has been requested.